Impact of vaccination on SARS-CoV-2 evolution and immune escape variants

Vaccine. 2024 Aug 30;42(21):126153. doi: 10.1016/j.vaccine.2024.07.054. Epub 2024 Jul 26.

Abstract

Vaccines and host genetic factors can influence the SARS-CoV-2 evolution and emergence of new variants. Even vaccinated cases get affected as virus continues to evolve, raising concerns about vaccine efficacy and the emergence of immune escape variants. Here, we have analyzed 2295 whole-genome sequences of SARS-CoV-2 collected from vaccinated and unvaccinated cases to evaluate the impact of vaccines on virus diversity within hosts. Our comparative analysis revealed a significant higher incidence of intra-host single nucleotides variants (iSNVs) in vaccinated cases compared to unvaccinated ones (p value<0.0001). Furthermore, we have found that specific mutational processes, including APOBEC (C > T) mediated and ADAR1 (A > G) mediated mutations, were found more prevalent in vaccinated cases. Vaccinated cases exhibited higher accumulation of nonsynonymous mutation than unvaccinated cases. Fixed iSNVs were predominantly located in the ORF1ab and spike genes, several key omicron defining immune escape variants S477N, Q493R, Q498R, Y505H, L452R, and N501Y were identified in the RBD domain of spike gene in vaccinated cases. Our findings suggest that vaccine plays an important role in the evolution of the virus genome. The virus genome acquires random mutations due to error-prone replication of the virus, host modification through APOBEC and ADAR1 mediated editing mechanism, and oxidative stress. These mutations become fixed in the viral population due to the selective pressure imposed by vaccination.

Keywords: COVID-19; Immune escape variants; Intra-host variations; SARS-CoV-2; Vaccine breakthrough infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / genetics
  • Adenosine Deaminase / immunology
  • COVID-19 Vaccines* / immunology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • COVID-19* / virology
  • Evolution, Molecular*
  • Genome, Viral
  • Humans
  • Immune Evasion* / genetics
  • Mutation*
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / immunology
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / immunology
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology
  • Vaccination*
  • Whole Genome Sequencing

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • RNA-Binding Proteins
  • ADAR protein, human
  • Adenosine Deaminase
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants